Novartis paid Takeda $3.4 billion for its FDA-approved dry eye drug Xiidra during the Japanese ... has just announced FDA approval of a phase 3 trial for eye drops containing tivanisiran, in ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

Generic Pataday Once Daily Relief Ophthalmic Solution (OTC) is used to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair and dander. Alembic has received tentative approval ...

There can be many reasons why you might find yourself looking for over-the-counter eye drops, including red, itchy or dry eyes. These symptoms can be caused by allergies, eye strain, dry air or ...

Novartis’ decision to withdraw a European filing for its dry-eye drug Xiidra is to have a knock-on effect on Takeda, causing it to make a loss of $200 million this quarter. Already approved ...

Restasis (cyclosporine) is a brand-name drug that’s prescribed for chronic dry eye in adults and certain children. Restasis comes as an eye drop solution. The typical dosage is one drop per ...

Luke Daugherty is a freelance writer, editor and former operations manager. His work covers operations, marketing, sustainable business and personal finance, as well as many of his personal ...

for its Abbreviated New Drug Application (ANDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7%, which is generic eye drops. "...this is to inform the exchange that the Company has ...

Restasis (cyclosporine) is a prescription drug that’s used to treat chronic ... Like other drugs, Restasis eye drops can cause mild to serious side effects. Keep reading to learn more.